跳至主要内容
临床试验/CTRI/2025/02/079853
CTRI/2025/02/079853尚未招募2 期

A RANDOMISED COMPARATIVE STUDY TO COMPARE THE EFFECTIVENESS OF INDIVIDUALISED HOMOEOPATHIC MEDICINE IN CENTESIMAL VERSUS FIFTY MILLESIMAL SCALE IN THE MANAGEMENT OF CHRONIC RHINOSINUSITIS

Dr Aruma Prakash1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年2月13日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
Primary outcome of treatment will be assessed by considering symptomatic improvement of the patient and X ray before and after treatment

研究概览

简要总结

It is a Randomised Comparative study to compare the effectiveness of Centesimal and fifty millesimal scale in management of chronic rhinosinusitis. Following obtaining consent on basis of selection criteria,minimum 60 patients will be included in the study.Following that baseline outcome data(rhinosinusitis symptoms, x ray findings,complete case taking)will be done on appropriate randomized procedure to receive individualized Homoeopathic medicine either in centennial or fifty millennial Potency in 1:1 ratio.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • 1.Patients willing to provide written informed consent.
  • 2.Patients of both sexes in age groups between 18-70 years.
  • 3.Patients having chronic sinusitis since 12weeks or more 4.Patients who have not taken any treatment since last 2wks for chronic sinusitis.

排除标准

  • 1.Patients suffering from other uncontrolled systemic diseases like cancer, uncontrolled infections or any vital organ failures.
  • 2.Patients suffering from chronic sinusitis complications 3.Psychiatrically unstable patients.
  • 4.Pregnant or lactating females.
  • 5.Immunocompromised patients.
  • 6.Significant renal impairment 7.Severe deviated nasal septum,patients having severe anatomical abnormalities of nose 8.Patients who are terminally ill, under immunosuppressive treatment or self reported immunocompromised state.
  • 9.Diagnosed case of mental illness/psychiatric/life threatening illness affecting quality of life/any organ failure.
  • 10.Substance abuse and/or dependance 11.Patients who are unwilling to take part or not giving consent to join the study or unable to read patient information.

结局指标

主要结局

Primary outcome of treatment will be assessed by considering symptomatic improvement of the patient and X ray before and after treatment

时间窗: One at baseline,in 6 months and in the end of the study.

次要结局

  • Will be assessed using Chronic Sinusitis Assesment Score(Assess at an interval of one month till completion of study)

研究者

发起方
Dr Aruma Prakash
申办方类型
Other [[self]]
责任方
Principal Investigator
主要研究者

Dr Aruma Prakash

Nehru Homoeopathic Medical College and Hospital

研究点 (1)

Loading locations...

相似试验